Package Leaflet: Information for the Patient
Barnidipine Teva 10 mg Hard Capsules, Modified Release EFG
barnidipine hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
The active substance of Barnidipine Teva belongs to a group of medicines called calcium channel blockers. Barnidipine causes a dilation of the blood vessels which leads to a reduction of blood pressure. Barnidipine Teva capsules are manufactured in a "prolonged release" form. This means that the active substance is absorbed gradually into the body and has a longer-lasting effect. This is why taking one dose per day is sufficient.
Barnidipine is used for the treatment of high blood pressure.
Do not takeBarnidipine Teva
Warnings and precautions
Consult your doctor or pharmacist before taking Barnidipine Teva
Children and adolescents
Barnidipine must not be used in children or adolescents under 18 years.
Other medicines and Barnidipine Teva
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
This is especially important if you are using any of the following medicines as they MUST NOTbe used with barnidipine (see "Do not take Barnidipine Teva"):
Also, inform your doctor if you are taking:
Taking Barnidipine Tevawith drinks and alcohol
Be particularly careful when drinking alcohol or grapefruit juice, as they may increase the effect of barnidipine.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Do not use this medicine during pregnancy unless clearly necessary.
Do not use this medicine while breast-feeding. Barnidipine may pass into breast milk.
Driving and using machines
There is no information to suggest that this medicine affects the ability to drive or use machines. However, as this medicine may cause dizziness, you should know how it affects you before driving or using machines.
Barnidipine Teva contains sucrose
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
The recommended initial dose is 10 mg once a day. Your doctor may increase this dose to 1 capsule of 20 mg once a day or 2 capsules of 10 mg once a day.
If you are an elderly person, you can take the normal dose. It is likely that your doctor will monitor you closely at the beginning of treatment.
Instructions for use
If you take more Barnidipine Tevathan you should
If you have accidentally taken a large number of capsules at once, you should immediatelyconsult your doctor or someone should take you to the emergency department. The possible symptoms of overdose include weakness, slowing or increased heart rate, drowsiness, confusion, nausea, vomiting, and convulsions.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Barnidipine Teva
If you forget to take your dose of barnidipine at the usual time, take it as soon as possible on the same day.
If more than 24 hours have passed, DO NOTtake a double dose to make up for the missed doses and continue with the usual schedule once a day.
If you have any other questions about the use of this medicine or want to stop treatment, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience a severe allergic reaction that causes difficulty breathing or dizziness, you should inform your doctor or nurse immediately.
Barnidipine may cause the following:
Frequent: may affect up to 1 in 10 people
Frequency not known: frequency cannot be estimated from the available data
These side effects tend to decrease or disappear during treatment (within a month for fluid accumulation and within two weeks for flushing, headache, and palpitations).
The following side effects have been observed in some of the other medicines belonging to the same group of medicines as barnidipine:
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not store above 25°C.
Do not use this medicine after the expiry date which is stated on the blister and on the carton after EXP. The expiry date is the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Barnidipine Teva
Contents of the capsule: sugar spheres (with sugar syrup, corn starch, and sucrose), carboxymethylcellulose, polysorbate 80, ethylcellulose, talc.
Body of the capsule: titanium dioxide (E171), yellow iron oxide (E172), gelatin.
Printing ink: Shellac, propylene glycol, black iron oxide (E172), potassium hydroxide.
Appearance ofBarnidipine Tevaand contents of the pack
Barnidipine Teva 10 mg hard capsules, modified release EFG are hard gelatin capsules filled with granules, yellow to yellowish in color. The cap of the capsule is yellow with black printing "1000" and the body is yellow with black printing "0010".
Available in perforated and non-perforated blisters of 28, 30, 56, or 60 capsules.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder:
Teva B.V.
Swensweg 5
2031 GA Haarlem
Netherlands
Manufacturer
Teva Nederland BV
Swensweg 5
Haarlem 2031 GA
Netherlands
or
Teva Operations Poland Sp. z.o.o
ul. Mogilska 80
Krakow, 31-546
Poland
or
Balkanpharma-Dupnitsa AD
3 Samokovsko Shosse Str.
Dupnitsa, 2600
Bulgaria
You can request more information about this medicine from the local representative of the marketing authorisation holder:
Teva Pharma, S.L.U
C/ Anabel Segura, 11, Edificio Albatros B, 1ª planta,
Alcobendas 28108, Madrid (Spain)
Date of last revision of this leaflet:February 2022
You can access detailed and updated information about this medicine by scanning the QR code included in the packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/info/87089
Detailed and updated information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/